Table 2.
Start of the study | End of the study (6 months) | Change in HbA1c | Group differenceaP value | |
---|---|---|---|---|
LGS | 7.6 [7.4, 7.9]; 46/46 | 7.5 [7.3, 7.7]; 46/46 | –0.1 [–0.3, 0.03] | 0.07 [–0.2; 0.3]; P = 0.55 |
SMBG | 7.4 [7.2, 7.6]; 49/49 | 7.4 [7.2, 7.7]; 49/49 | –0.06 [–0.2, 0.09] |
Result from mixed-effects model repeated measures, adjusted according to HbA1c value at the start of the study, visit interaction, age group interaction, as well as age group × visit interaction, age group × treatment group interaction, and treatment group × visit interaction. n, number of patients analyzed; N, number of randomized patients.